Shattuck Labs, Inc.(STTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

STTK Shattuck Labs, Inc.

Market Closed 11-22 16:00:00 EST

1.01

+0.00

-0.50%

盘后1.04

+0.04+3.48%

18:43 EST

High1.03	Low0.9400	Vol393.84K
Open0.9900	D1 Closing1.01	Amplitude8.42%
Mkt Cap47.98M	Tradable Cap27.38M	Total Shares47.74M
T/O393.47K	T/O Rate1.45%	Tradable Shares27.24M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"STTK","market":"US","secType":"STK","nameCN":"Shattuck Labs, Inc.","latestPrice":1.005,"timestamp":1732309200000,"preClose":1.01,"halted":0,"volume":393841,"hourTrading":{"tag":"盘后","latestPrice":1.04,"preClose":1.005,"latestTime":"18:43 EST","volume":1182,"amount":1227.28,"timestamp":1732319022160},"delay":0,"floatShares":27241447,"shares":47739708,"eps":-1.524895,"marketStatus":"Market Closed","change":-0.005,"latestTime":"11-22 16:00:00 EST","open":0.99,"high":1.025,"low":0.94,"amount":393474.078362,"amplitude":0.084158,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.524895,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732525200000},"marketStatusCode":7,"adr":0,"listingDate":1602216000000,"exchange":"NASDAQ","adjPreClose":1.01,"preHourTrading":{"tag":"盘前","latestPrice":1.06,"preClose":1.01,"latestTime":"09:19 EST","volume":396,"amount":401.25998880000003,"timestamp":1732285181927},"postHourTrading":{"tag":"盘后","latestPrice":1.04,"preClose":1.005,"latestTime":"18:43 EST","volume":1182,"amount":1227.28,"timestamp":1732319022160},"volumeRatio":1.5838045345289267,"impliedVol":0.6406,"impliedVolPercentile":0.1032},"requestUrl":"/m/hq/s/STTK/wiki","defaultTab":"wiki","newsList":[{"id":"2483513889","title":"Shattuck Labs Third Quarter 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2483513889","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483513889?lang=en_us&edition=fundamental","pubTime":"2024-11-16 20:11","pubTimestamp":1731759083,"startTime":"0","endTime":"0","summary":"NasdaqGS:STTK Earnings and Revenue History November 16th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates significantly. Earnings per share  also surpassed analyst estimates by 16%.Looking ahead, revenue is expected to decline by 49% p.a. on average during the next 3 years, while revenues in the Biotechs industry in the US are expected to grow by 22%.The company's shares are up 4.7% from a week ago.We don't want to rain on the parade too much, but we did also find 5 warning signs for Shattuck Labs (2 are concerning!) that you need to be mindful of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shattuck-labs-third-quarter-2024-121123081.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["STTK"],"gpt_icon":0},{"id":"2483221643","title":"Shattuck Labs sees cash runway into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2483221643","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483221643?lang=en_us&edition=fundamental","pubTime":"2024-11-15 20:12","pubTimestamp":1731672767,"startTime":"0","endTime":"0","summary":"Shattuck has effectuated its restructuring plan to prioritize the development of the DR3 program and align the Company’s cost and workforce structure with the its current goals and clinical development strategy. The Company has substantially completed the reduction in force associated with the discontinuation of SL-172154. Shattuck believes its cash and cash equivalents and investments will be sufficient to fund its planned operations into 2027, beyond results from its Phase 1 clinical trial of SL-325. This cash runway guidance is based on the Company’s current operational plans and excludes any additional capital that may be received, proceeds from potential business development transactions, and/or additional costs associated with additional development activities that may be undertaken.Shattuck Labs downgraded to Hold from Buy at Needham. Shattuck Labs downgraded to Neutral from Buy at Citi. Shattuck Labs downgraded to Neutral from Buy at H.C. Wainwright","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/6MInUe1T4fs5TaG11G3efw--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/87b9ff78d08b9d461f46ab67f57ff730","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/6MInUe1T4fs5TaG11G3efw--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/87b9ff78d08b9d461f46ab67f57ff730"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/shattuck-labs-sees-cash-runway-121247444.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shattuck-labs-sees-cash-runway-121247444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2483736847","title":"TD Cowen Reaffirms Their Buy Rating on Shattuck Labs (STTK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483736847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483736847?lang=en_us&edition=fundamental","pubTime":"2024-11-15 08:05","pubTimestamp":1731629129,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Marc Frahm maintained a Buy rating on Shattuck Labs (STTK – Research Report) yesterday. The company’s shares closed yesterday at $...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-shattuck-labs-sttk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-shattuck-labs-sttk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COWN","TD","STTK"],"gpt_icon":0},{"id":"2483011806","title":"Shattuck Labs Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483011806","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483011806?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:15","pubTimestamp":1731593757,"startTime":"0","endTime":"0","summary":"* Shattuck Labs Inc    reported a quarterly adjusted loss of 33 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -65 cents. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"gpt_icon":0},{"id":"2483809685","title":"Shattuck Labs: Navigating Strategic Shift to Autoimmune Pipeline Amidst Financial Stability and Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2483809685","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483809685?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:15","pubTimestamp":1731593710,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis has maintained their neutral stance on STTK stock, giving a Hold rating today. Joseph Pantginis has given ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/shattuck-labs-navigating-strategic-shift-to-autoimmune-pipeline-amidst-financial-stability-and-hold-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/shattuck-labs-navigating-strategic-shift-to-autoimmune-pipeline-amidst-financial-stability-and-hold-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["STTK"],"gpt_icon":0},{"id":"2483776038","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Shattuck Labs (STTK) and Astria Therapeutics (ATXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483776038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483776038?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:02","pubTimestamp":1731589325,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN – Research Report), Shattuck Labs (STTK – Research Re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-shattuck-labs-sttk-and-astria-therapeutics-atxs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-shattuck-labs-sttk-and-astria-therapeutics-atxs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","LU1571399168.USD","BK4585","AMGN","LU0122379950.USD","IE0002141913.USD","LU0889565916.HKD","LU0289739699.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","BK4566","SG9999001440.SGD","BK4137","BK4533","LU1023059063.AUD","HCSG","LU2242652126.USD","IE00B4R5TH58.HKD","LU0868494617.USD","ATXS","IE0009355771.USD","LU2112291526.USD","BK4534","LU2242646821.SGD","BK4581","BK4588","IE00BFTCPJ56.SGD","LU1983299246.USD","STTK","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0109394709.USD","LU1061106388.HKD","BK4139"],"gpt_icon":0},{"id":"2483871332","title":"Shattuck Labs' Cash Balance Of Approximately $90M As Of September 30, 2024; Expected To Fund Operations Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2483871332","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483871332?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:21","pubTimestamp":1731586887,"startTime":"0","endTime":"0","summary":"Financial GuidanceShattuck has effectuated its restructuring plan to prioritize the development of the DR3 program and align the Company&#39;s cost and workforce structure with the its current goals and clinical development","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/24/11/41968584/shattuck-labs-cash-balance-of-approximately-90m-as-of-september-30-2024-expected-to-fund-operatio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2483871358","title":"Shattuck Labs Q3 2024 GAAP EPS $(0.33) Beats $(0.42) Estimate, Sales $3.00M May Not Be Comparable To $652.25K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483871358","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483871358?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:20","pubTimestamp":1731586829,"startTime":"0","endTime":"0","summary":"Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.42) by 21.43 percent. This is a 49.23 percent increase over losses of $(0.65) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41968535/shattuck-labs-q3-2024-gaap-eps-0-33-beats-0-42-estimate-sales-3-00m-may-not-be-comparable-to-652-25","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Shattuck Labs Q3 2024 GAAP EPS $(0.33) Beats $(0.42) Estimate, Sales $3.00M May Not Be Comparable To $652.25K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"gpt_icon":0},{"id":"2483639876","title":"BRIEF-Shattuck Labs Q3 Net Income USD -16.675 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483639876","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483639876?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:00","pubTimestamp":1731585645,"startTime":"0","endTime":"0","summary":"BRIEF-Shattuck Labs Q3 Net Income USD -16.675 Million\n\n\nNov 14 (Reuters) - Shattuck Labs Q3 income from operations USD -17.92 million.\n\nQ3 basic EPS USD -0.33\nQ3 collaboration revenue USD 2.997 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nPLXE67B32:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2483487635","title":"Shattuck Labs Q3 Net Income USD -16.675 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483487635","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483487635?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:00","pubTimestamp":1731585600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nPLXE67B32:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2483309876","title":"Shattuck Labs Q3 Income From Operations USD -17.92 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309876","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483309876?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:00","pubTimestamp":1731585600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nPLXE67B32:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2483087659","title":"Shattuck Labs Q3 Collaboration Revenue USD 2.997 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483087659","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483087659?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:00","pubTimestamp":1731585600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nPLXE67B32:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2483876507","title":"Shattuck Labs Q3 Basic EPS USD -0.33","url":"https://stock-news.laohu8.com/highlight/detail?id=2483876507","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483876507?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:00","pubTimestamp":1731585600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nPLXE67B32:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2483788876","title":"Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2483788876","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483788876?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:00","pubTimestamp":1731585600,"startTime":"0","endTime":"0","summary":"– Announced development of SL-325, a first-in-class antagonist antibody to DR3, the receptor for TL1A; IND filing expected in Q3'2025 – – Cash balance of approximately $90M as of September 30, 2024; e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/14/2981013/0/en/Shattuck-Labs-Reports-Third-Quarter-2024-Financial-Results-and-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","STTK"],"gpt_icon":0},{"id":"2481600734","title":"Shattuck Labs Inc  expected to post a loss of 42 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481600734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481600734?lang=en_us&edition=fundamental","pubTime":"2024-11-06 22:29","pubTimestamp":1730903347,"startTime":"0","endTime":"0","summary":"Shattuck Labs Inc  expected to post a loss of42cents a share - Earnings Preview Shattuck Labs Inc STTK.OQ STTK.O is expected to show a fall in quarterly revenue when it reports  results on November 7 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL8N3MD3AX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"gpt_icon":0},{"id":"2472573570","title":"Shattuck cut to Neutral at Citi on program exit","url":"https://stock-news.laohu8.com/highlight/detail?id=2472573570","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472573570?lang=en_us&edition=fundamental","pubTime":"2024-10-02 22:55","pubTimestamp":1727880937,"startTime":"0","endTime":"0","summary":"Following a ~44% plunge in the previous session in reaction to its decision to drop lead asset SL-172154 from its pipeline, shares of Shattuck Labs  continued to tumble on Wednesday as Citi downgraded the drug developer to neutral from buy. Citing Phase 1 data the company announced, Citi analyst Yigal Nochomovitz noted that SL-172154 with chemotherapy azacitidine has failed to impress against myeloid leukemia and myelodysplastic syndromes compared to azacitidine alone. Despite the downgrade, he commended the company for taking a “disciplined decision” instead of “signal chasing.” However, Nochomovitz pointed out that Shattuck’s  latest focus, an experimental bowel disease therapy called SL-325, is at least a year from reaching the clinic and unlikely to generate a near-term stock-moving event. Removing all future revenue linked to SL-172154, the analyst also slashed his price target on STTK to $2 from $8 to reflect only the cash level the company is projected to have at the end of Q3 2","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/185078746/image_185078746.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/185078746/image_185078746.jpg"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4155544-shattuck-stock-cut-citi-program-exit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["STTK"],"gpt_icon":0},{"id":"2472573535","title":"STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2472573535","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472573535?lang=en_us&edition=fundamental","pubTime":"2024-10-02 22:21","pubTimestamp":1727878860,"startTime":"0","endTime":"0","summary":"Shattuck Labs STTK announced its decision to discontinue the development of its pipeline candidate SL-172154, which was being developed for acute myeloid leukemia  and higher-risk myelodysplastic syndromes , types of blood cancer, as part of its strategic pipeline prioritization efforts. This disappointed investors as SL-172154 was the only clinical-stage candidate in Shattuck’s pipeline. Following the news, the stock plummeted 45% on Tuesday and lost another 3.7% during the after-market hours.STTK's Phase IB SL-172154 Study Shows Limited Efficacy. Shattuck’s phase IB study evaluated SL-172154, combined with Bristol Myers’ BMY Vidaza/Onureg , to treat patients with TP53 mutant  AML and HR-MDS. Per the interim analysis results, treatment with the combo therapy in the MDS arm showed a median OS of 10.6 months, which will not improve beyond 13.1 months with subsequent data cuts. The benchmark median OS for TP53m HR-MDS patients treated with Vidaza/Onureg monotherapy is approximately 9-12 ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sb.6qRd7FfGt7.wCjWz2vw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sb.6qRd7FfGt7.wCjWz2vw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sttk-discontinues-cancer-program-plans-142100969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU2125154778.USD","LU0225284248.USD","LU1032466523.USD","LU1585245621.USD","IE00BJT1NW94.SGD","LU0306807586.USD","LU2242652126.USD","BK4139","LU2133065610.SGD","FULC","IE00BFTCPJ56.SGD","LU0868494617.USD","LU1718418525.SGD","LU1093756325.SGD","LU0321505868.SGD","BMY","LU0237698245.USD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU0225771236.USD","LU1093756168.USD","LU1261432733.SGD","LU0321505439.SGD","LU1074936037.SGD","LU2125154935.USD","ANIP","BK4559","BK4097","IE00B2B36J28.USD","LU0114720955.EUR","BK4581","LU1430594728.SGD","BK4532","LU1670711040.USD","BK4534","LU0882574055.USD","LU1571399168.USD","LU1670711123.USD","OS","IE0009355771.USD","STTK","BK4585","LU1670710588.SGD","LU1989771016.USD","LU0985481810.HKD","LU1670710661.SGD","BK4007","LU0306806265.USD","LU0061475181.USD"],"gpt_icon":0},{"id":"2472542495","title":"Evercore ISI Keeps Their Buy Rating on Shattuck Labs (STTK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2472542495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472542495?lang=en_us&edition=fundamental","pubTime":"2024-10-02 20:16","pubTimestamp":1727871403,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Jonathan Miller maintained a Buy rating on Shattuck Labs (STTK – Research Report) today. The company’s shares closed yesterday...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evercore-isi-keeps-their-buy-rating-on-shattuck-labs-sttk-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evercore-isi-keeps-their-buy-rating-on-shattuck-labs-sttk-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["STTK"],"gpt_icon":0},{"id":"2472545218","title":"Needham Downgrades Shattuck Labs to Hold From Buy, Price Target is $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2472545218","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472545218?lang=en_us&edition=fundamental","pubTime":"2024-10-02 19:00","pubTimestamp":1727866846,"startTime":"0","endTime":"0","summary":"Price: 1.4000, Change: -2.09, Percent Change: -59.89","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["STTK"],"gpt_icon":0},{"id":"2472172345","title":"Citigroup Downgrades Shattuck Labs to Neutral From Buy, Adjusts Price Target to $2 From $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2472172345","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472172345?lang=en_us&edition=fundamental","pubTime":"2024-10-02 17:54","pubTimestamp":1727862879,"startTime":"0","endTime":"0","summary":"Price: 1.8500, Change: -0.07, Percent Change: -3.65","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["STTK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shattucklabs.com","stockEarnings":[{"period":"1week","weight":-0.1862},{"period":"1month","weight":-0.2269},{"period":"3month","weight":-0.7129},{"period":"6month","weight":-0.8658},{"period":"1year","weight":-0.5687},{"period":"ytd","weight":-0.859}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.223897},{"month":2,"riseRate":0.25,"avgChangeRate":-0.096809},{"month":3,"riseRate":0.25,"avgChangeRate":-0.198268},{"month":4,"riseRate":0.75,"avgChangeRate":0.095681},{"month":5,"riseRate":0,"avgChangeRate":-0.22685},{"month":6,"riseRate":0.75,"avgChangeRate":0.034283},{"month":7,"riseRate":0.25,"avgChangeRate":-0.11323},{"month":8,"riseRate":0,"avgChangeRate":-0.1098},{"month":9,"riseRate":0,"avgChangeRate":-0.132219},{"month":10,"riseRate":0.25,"avgChangeRate":-0.161173},{"month":11,"riseRate":0.4,"avgChangeRate":-0.059537},{"month":12,"riseRate":1,"avgChangeRate":0.775975}],"exchange":"NASDAQ","name":"Shattuck Labs, Inc.","nameEN":"Shattuck Labs, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shattuck Labs, Inc.(STTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shattuck Labs, Inc.(STTK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shattuck Labs, Inc.,STTK,Shattuck Labs, Inc.股票,Shattuck Labs, Inc.股票老虎,Shattuck Labs, Inc.股票老虎国际,Shattuck Labs, Inc.行情,Shattuck Labs, Inc.股票行情,Shattuck Labs, Inc.股价,Shattuck Labs, Inc.股市,Shattuck Labs, Inc.股票价格,Shattuck Labs, Inc.股票交易,Shattuck Labs, Inc.股票购买,Shattuck Labs, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shattuck Labs, Inc.(STTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shattuck Labs, Inc.(STTK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction